Mackenzie Financial Corp Amicus Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

  • $71.6 Billion
  • Q2 2025

A detailed history of Mackenzie Financial Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 139,207 shares of FOLD stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
139,207
Previous 42,605 226.74%
Holding current value
$1.17 Million
Previous $347,000 129.68%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$5.64 - $8.0 $544,835 - $772,816
96,602 Added 226.74%
139,207 $797,000
Q1 2025

May 07, 2025
BUY
$8.16 - $9.85 $164,073 - $198,053
20,107 Added 89.37%
42,605 $347,000
Q4 2024

Feb 14, 2025
SELL
$9.36 - $12.01 $59,707 - $76,611
-6,379 Reduced 22.09%
22,498 $211,000
Q3 2024

Nov 13, 2024
BUY
$9.55 - $12.09 $16,024 - $20,287
1,678 Added 6.17%
28,877 $308,000
Q2 2024

Aug 14, 2024
BUY
$9.04 - $11.75 $1,726 - $2,244
191 Added 0.71%
27,199 $269,000
Q1 2024

May 10, 2024
SELL
$11.43 - $14.24 $23,420 - $29,177
-2,049 Reduced 7.05%
27,008 $318,000
Q4 2023

Jan 30, 2024
BUY
$9.97 - $14.52 $42,472 - $61,855
4,260 Added 17.18%
29,057 $412,000
Q3 2023

Oct 25, 2023
SELL
$11.78 - $13.86 $219,956 - $258,793
-18,672 Reduced 42.95%
24,797 $301,000
Q2 2023

Aug 03, 2023
SELL
$10.72 - $13.3 $82,661 - $102,556
-7,711 Reduced 15.07%
43,469 $545,000
Q1 2023

Apr 24, 2023
BUY
$10.91 - $13.54 $92,625 - $114,954
8,490 Added 19.89%
51,180 $567,000
Q4 2022

Feb 14, 2023
SELL
$9.89 - $12.7 $144,008 - $184,924
-14,561 Reduced 25.43%
42,690 $521,000
Q3 2022

Oct 07, 2022
SELL
$9.82 - $12.75 $209,912 - $272,544
-21,376 Reduced 27.19%
57,251 $598,000
Q2 2022

Aug 10, 2022
BUY
$6.23 - $11.12 $129,272 - $230,739
20,750 Added 35.85%
78,627 $844,000
Q1 2022

May 13, 2022
SELL
$7.89 - $12.48 $2,619 - $4,143
-332 Reduced 0.57%
57,877 $548,000
Q4 2021

Feb 14, 2022
SELL
$9.82 - $12.44 $10,075 - $12,763
-1,026 Reduced 1.73%
58,209 $672,000
Q3 2021

Nov 08, 2021
BUY
$8.74 - $11.84 $56,923 - $77,113
6,513 Added 12.35%
59,235 $566,000
Q2 2021

Aug 11, 2021
BUY
$8.71 - $10.72 $139,760 - $172,013
16,046 Added 43.75%
52,722 $508,000
Q1 2021

May 14, 2021
BUY
$9.2 - $23.86 $157,366 - $408,125
17,105 Added 87.4%
36,676 $362,000
Q4 2020

Feb 10, 2021
SELL
$13.47 - $24.89 $534,947 - $988,481
-39,714 Reduced 66.99%
19,571 $452,000
Q3 2020

Nov 13, 2020
BUY
$12.89 - $15.89 $225,059 - $277,439
17,460 Added 41.75%
59,285 $837,000
Q2 2020

Aug 13, 2020
BUY
$8.86 - $15.69 $370,569 - $656,234
41,825 New
41,825 $630,000

Others Institutions Holding FOLD

# of Institutions
304
Shares Held
332M
Call Options Held
396K
Put Options Held
249K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.37B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email